| Name | Title | Contact Details |
|---|---|---|
Andrew McCann |
Chief Technology Officer | Profile |
Premier Diagnostic Health Services Inc. (“Premier”, “PDH” or the “Company”) is a Canadian corporation with its head office in Burnaby, British Columbia. PDH designs, finances, builds and operates free standing diagnostic imaging centres with no outside affiliation in Canada, and joint venture, diagnostic imaging centres in China with local hospitals. PDH specializes in PET/CT and MRI scanning for the detection and evaluation of cancer, heart disease and neurological disorders
Medical Claims Assistance is a Huntington, WV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MedData is a leading national provider of technology-enabled healthcare services designed to improve financial outcomes for hospitals by enhancing the patient experience and expanding their access to healthcare. The MedData suite of solutions includes a range of patient access & communications, revenue cycle management, and consulting & analytics services, including full service billing & coding, patient balances, eligibility & disability, third party liability and other complex A/R services, and mobile-first engagement and communication software for patients and providers. MedData has built this national presence by becoming experts at the state level. To date, we have handled billing for more than 200 million patients at our growing network of more than 2,000 hospital sites nationwide. For more than 36 years, MedData has solidified its leadership position by providing innovative solutions to the medical community and serving millions of patients across numerous medical specialties.
NYMOZARFEX (TM) is given in an in-office procedure that is administered in a few minutes without need of anesthesia or analgesia. The drug has been tested in clinical trials involving overall more than 1750 patients with over 1600 injections administered including over 1200 Fexapotide administrations. Fexapotide has led to significant long-term improvements and has shown an excellent safety profile without the side effects normally associated with existing BPH treatments.
Varian Medical Systems` vision is a world without fear of cancer. To meet this challenge, we equip the world with new tools for fighting cancer. Since the 1950s we have been producing tools that harness the power of X-ray energy to benefit humankind. Our history is one of pioneering developments in the fields of radiotherapy, radiosurgery, X-ray tube technology, digital image detectors, cargo screening, and non-destructive testing. Today, we have a robust product portfolio and long-standing relationships with many of the world`s leading clinicians. As Varian continues to grow, our staff of over 6,500 people in 70 sales and support offices around the globe is developing innovative, cost-effective solutions that help make the world a healthier place. Varian reserves the right to remove any comment for any reason and ban any user from its page at is sole discretion. Varian does not endorse user comments on its page and cannot confirm their accuracy. User comments do not necessarily represent the ideas, thoughts, beliefs, opinions or views of Varian, or any of its affiliates.